Continuing with the success of last year’s NextGen VC Forum, we’re back on the West Coast on Tuesday, May 6, with three new panel discussions: Biotech, AI, and the Law: Today’s Legal Considerations, Biotech Companies and Investors Facing a Growing National Security Regulatory Thicket, and From US to China: The Legal Playbook for Biotech Spinouts. This is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. Space is limited; learn more and request an invite here: https://lnkd.in/exQnbFdg In partnership with Wilson Sonsini Goodrich & Rosati
LaunchBio Inc.
生物技术
San Diego，CA 3,971 位关注者
A nonprofit organization that delivers programming designed to connect life science entrepreneurs and investors.
关于我们
LaunchBio is a nonprofit organization formed to identify, counsel, and support high-growth, high-impact life science and biotechnology companies through regional and national collaboration with ecosystem partners. LaunchBio’s mission is to build an ecosystem of innovation for the benefit of human health and well-being.
- 网站
-
http://www.launchbio.org
LaunchBio Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- San Diego，CA
- 类型
- 非营利机构
- 创立
- 2017
- 领域
- Biotechnology和Science
地点
LaunchBio Inc.员工
动态
-
More great insights on gene therapy! Thanks to Fondation Ipsen for sharing Dr Stephanie Cherqui's expertise, which was captured at our February Invest in Cures forum!
🎥 What is Gene Therapy? For people living with rare diseases, traditional medicine isn’t always enough. But gene therapy offers new hope by addressing the root cause of these conditions. In this video, Dr. Stephanie Cherqui explains how gene therapy works and why it could transform treatment for rare genetic diseases. 👉 Watch now to learn more about this groundbreaking approach: https://lnkd.in/eVFbT_Pi #GeneTherapy #RareDisease #Biotech #Innovation This video was filmed at the #InvestinCures event by LaunchBio Inc.
-
🎤 NextGen VC Podcast alert! 🎤 Join hosts Michael Hostetler and Jennifer Fang of Wilson Sonsini Goodrich & Rosati as they are joined by Felix Breyer, PhD of J.P. Morgan Life Sciences Private Capital. Felix, with a background as a molecular and cellular biologist, dives deep into the critical role of private capital in life sciences and biotech. He shares his journey from academia to venture capital, emphasizes the importance of mentorship, and provides an insider’s perspective on the evolving landscape of biotech investing. Tune in to explore key trends, challenges, and opportunities in the biotech sector, and gain valuable insights for aspiring venture capitalists. Listen here: https://lnkd.in/ey9V_RHK #VentureCapital #HealthcareInnovation #Podcast #LifeSciences #WSLifeSci #BuildingBetterBiotechs
-
-
We're pleased to announce the launch of Investor Connect RARE! We'll be joined by the Cystic Fibrosis Foundation on June 11. We'll be sharing the schdule featuring other rare disease foundations in the coming weeks. Learn more and apply today: https://lnkd.in/gJ5qWEgW
-
-
Don't miss these great insights from Lydia McClure (Research Bridge Partners). Thanks to Fondation Ipsen for putting this together at Invest in Cures!
💡 How does disruption fuel breakthrough science? 🎙️ At LaunchBio Inc.’s Invest in Cures Event, Dr. Lydia McClure, CEO of Research Bridge Partners, shared how disruption shapes investment decisions in scientific innovation: “Finding the points of nexus where innovation happens across disciplines is crucial.” 🎥 Learn more about how cutting-edge science becomes life-saving therapies: https://lnkd.in/eW4QYWMG #Innovation #Disruption #Biotech #InvestInCures #LaunchBio #RareDisease #RareDiseaseTreatment
-
Our next virtual Investor Connect is March 27 with Lilly Ventures. They deploy customized engagement models to co-invest with world-class syndicate partners and offer counsel and connections within its global network with the goal of maximizing a company’s scientific impact. Learn more and apply today: https://lnkd.in/ekZF3n36 Together with Browne Consulting and Silicon Valley Bank
-
-
BioLabs extended their Investor Day deadline! Learn more below.
Business Operations & Strategy Director + Head of BioLabs for Advanced Therapeutics Philadelphia 🏳️🌈
Okay, we heard you — it's been a tough couple weeks. So we're excited to announce that we're extending the deadline for Investor Day to FRIDAY at midnight! #biolabsinvestorday APPLY NOW AND SPREAD THE WORD: https://lnkd.in/ekhwc3KH
-
-
The Chordoma Foundation recently launched the TBXT Challenge, offering $500K+ in prizes for key milestones towards drugging the emerging cancer target TBXT, also known as Brachyury. Designed to spur application of new technologies—including AI and computational approaches—to this target, the initial phase of the challenge seeks compounds that bind potently to the TBXT protein, which could serve as warheads for degraders or scaffolds for functional inhibitors. Companies and investigators are invited to submit up to 96 compounds for free biophysical evaluation. Additionally, the Chordoma Foundation can provide various resources to facilitate compound discovery including purified protein, expression vectors, protocols, and more. Learn more: https://tbxtchallenge.org/
-
Congrats to Morgan Thelander and Jody K. Thelander on their recent Forbes feature: https://lnkd.in/eAwpYV7N Catch them for FREE on our next Compensation Confidential webinar on April 24. Lear more and register today: https://lnkd.in/exY3c7G5
-
-
We are pleased to welcome OneDigital as our newest partner for 2025! We look forward to building better biotechs together.
-